Featured Studies
Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.
- Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder.
Interventional study. This study will compare the effects that two types of behavioral therapy have on brain function in people with social anxiety disorder. Ages 18-45. Location in Los Angeles, CA.
- Effect of D-Cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia.
Interventional study. This study will assess the effectiveness of D-cycloserine combined with cognitive-behavior therapy in treating people with social anxiety disorder. Ages 18 and over. Location in Boston, MA.
- Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia.
Interventional study. This study examines whether an antibiotic, d-cycloserine (DCS), boosts the effectiveness of cognitive behavior therapy (CBT) for social anxiety. Ages 8-55. Location in Bethesda, MD.
Search ClinicalTrials.gov for other NIH studies on Social Phobia (Social Anxiety Disorder).
Related Information
- Learn more about Social Phobia (Social Anxiety Disorder)
Social Phobia, or Social Anxiety Disorder, is an anxiety disorder characterized by overwhelming anxiety and excessive self-consciousness in everyday social situations. Social phobia can be limited to only one type of situation—such as a fear of speaking in formal or informal situations, or eating or drinking in front of others — or, in its most severe form, may be so broad that a person experiences symptoms almost anytime they are around other people.
Clinical Research at NIMH
- For opportunities to participate in NIMH research on the NIH campus, visit the patient recruitment Website. Travel and lodging assistance available.
